Analogously to compound 13, the hydroxyquinoline derivative 15 (Figure 3, YUM70) was able to downregulate KRAS, leading to antiproliferative and pro-apoptotic effects on KRAS-mutant cancer cells [73]. Here, KRAS is linked to cancer.